Carr BI - Search Results

1

Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis.

Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF, Goin K, Van Buskirk M, Thurston K. Goin JE, et al. Among authors: carr bi. J Vasc Interv Radiol. 2005 Feb;16(2 Pt 1):195-203. doi: 10.1097/01.RVI.0000142602.79459.90. J Vasc Interv Radiol. 2005. PMID: 15713920 Clinical Trial.

2

Yttrium-90 microspheres: radiation therapy for unresectable liver cancer.

Salem R, Thurston KG, Carr BI, Goin JE, Geschwind JF. Salem R, et al. Among authors: carr bi. J Vasc Interv Radiol. 2002 Sep;13(9 Pt 2):S223-9. doi: 10.1016/s1051-0443(07)61790-4. J Vasc Interv Radiol. 2002. PMID: 12354840 Review.

3

Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinoma.

Ebied OM, Federle MP, Carr BI, Pealer KM, Li W, Amesur N, Zajko A. Ebied OM, et al. Among authors: carr bi. Cancer. 2003 Feb 15;97(4):1042-50. doi: 10.1002/cncr.11111. Cancer. 2003. PMID: 12569604 Free article.

4

Yttrium-90 microspheres for the treatment of hepatocellular carcinoma.

Geschwind JF, Salem R, Carr BI, Soulen MC, Thurston KG, Goin KA, Van Buskirk M, Roberts CA, Goin JE. Geschwind JF, et al. Among authors: carr bi. Gastroenterology. 2004 Nov;127(5 Suppl 1):S194-205. doi: 10.1053/j.gastro.2004.09.034. Gastroenterology. 2004. PMID: 15508085

5

Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities.

Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF, Goin K, Van Buskirk M, Thurston K. Goin JE, et al. Among authors: carr bi. J Vasc Interv Radiol. 2005 Feb;16(2 Pt 1):205-13. doi: 10.1097/01.rvi.00001142592.89564.f9. J Vasc Interv Radiol. 2005. PMID: 15713921 Clinical Trial.

6

The effects of hepatic artery chemotherapy on viral hepatitis in patients with hepatocellular carcinoma.

Ahmad J, Rhee J, Carr BI. Ahmad J, et al. Among authors: carr bi. Dig Dis Sci. 2005 Feb;50(2):331-5. doi: 10.1007/s10620-005-1606-0. Dig Dis Sci. 2005. PMID: 15745096

7

Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.

Kulik LM, Carr BI, Mulcahy MF, Lewandowski RJ, Atassi B, Ryu RK, Sato KT, Benson A 3rd, Nemcek AA Jr, Gates VL, Abecassis M, Omary RA, Salem R. Kulik LM, et al. Among authors: carr bi. Hepatology. 2008 Jan;47(1):71-81. doi: 10.1002/hep.21980. Hepatology. 2008. PMID: 18027884 Clinical Trial.

8

Clinicopathologic factors affecting patient survival and tumor recurrence after orthotopic liver transplantation for hepatocellular carcinoma.

Yokoyama I, Sheahan DG, Carr B, Kakizoe S, Selby R, Tzakis AG, Todo S, Iwatsuki S, Starzl TE. Yokoyama I, et al. Transplant Proc. 1991 Aug;23(4):2194-6. Transplant Proc. 1991. PMID: 1651577 No abstract available.

9

Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases.

Flickinger JC, Epstein AH, Iwatsuki S, Carr BI, Starzl TE. Flickinger JC, et al. Among authors: carr bi. Cancer. 1991 Jul 15;68(2):289-94. doi: 10.1002/1097-0142(19910715)68:2<289::aid-cncr2820680213>3.0.co;2-2. Cancer. 1991. PMID: 2070327 Free PMC article.

10

Liver transplantation for hepatocellular carcinoma.

Selby R, Kadry Z, Carr B, Tzakis A, Madariaga JR, Iwatsuki S. Selby R, et al. World J Surg. 1995 Jan-Feb;19(1):53-8. doi: 10.1007/BF00316980. World J Surg. 1995. PMID: 7740811

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

307 results

Search Page

Filters